CCL Products Intrinsic Value
CCL Products intrinsic value. CCL Products (CCL) median intrinsic value is ₹1815.00 from 10 valuation models (range ₹272–₹2269), vs current price ₹907.50 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Compare with CCL DCF valuation to assess whether the stock is under or overvalued.
CCL Valuation Methods Summary — DCF, Graham Number & P/E
CCL Products intrinsic value across 10 models vs current price ₹907.50 — upside/downside and value range per method. For current market price and key ratios, visit CCL Products stock price NSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹977.00 | ₹781.60 - ₹1172.40 | +7.7% | EPS: ₹39.08, Sector P/E: 25x |
| Book Value Method | asset | ₹2171.30 | ₹1954.17 - ₹2388.43 | +139.3% | Book Value/Share: ₹868.52, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹1815.00 | ₹1633.50 - ₹1996.50 | +100.0% | Revenue/Share: ₹1801.48, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹1815.00 | ₹1633.50 - ₹1996.50 | +100.0% | EBITDA: ₹868.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹2268.75 | ₹1815.00 - ₹2722.50 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹272.25 | ₹245.03 - ₹299.48 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹724.54 | ₹652.09 - ₹796.99 | -20.2% | Revenue Growth: 6.0%, Adj P/E: 18.5x |
| ROE Based Valuation | profitability | ₹1815.00 | ₹1633.50 - ₹1996.50 | +100.0% | ROE: 22.2%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹873.89 | ₹786.50 - ₹961.28 | -3.7% | EPS: ₹39.08, BVPS: ₹868.52 |
| Dividend Yield Method | dividend | ₹272.25 | ₹245.03 - ₹299.48 | -70.0% | DPS: ₹5.75, Target Yield: 3.0% |
CCL Intrinsic Value vs Market Price — All Valuation Models
CCL Products fair value range ₹272–₹2269 vs current market price ₹907.50 across 10 valuation models. Read CCL Products dividend policy for the complete payout history and dividend yield track record.
CCL Intrinsic Value Analysis — Undervalued or Overvalued?
CCL Products median intrinsic value ₹1815.00, current price ₹907.50 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of CCL?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of CCL Products (CCL) is ₹1815.00 (median value). With the current market price of ₹907.50, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹272.25 to ₹2268.75, indicating ₹272.25 - ₹2268.75.
Is CCL undervalued or overvalued?
Based on our multi-method analysis, CCL Products (CCL) appears to be trading below calculated value by approximately 100.0%.
CCL Financial Health — Key Ratios vs Industry Benchmarks
CCL Products financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 22.2% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 18.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.12x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
CCL Cash Flow Quality — Operating & Free Cash Flow
CCL Products operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹858 Cr | ₹858 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹290 Cr | ₹83 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹55 Cr | ₹-209 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹173 Cr | ₹20 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹116 Cr | ₹20 Cr | Positive Free Cash Flow | 7/10 |